1-7 of 7
jak2 gene v617f
Close
Sort by
Journal Articles

JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedside

Jason Gotlib
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 529–537.
https://doi.org/10.1182/asheducation-2013.1.529
Published: 2013
Journal Articles

Beyond JAK inhibitor therapy in myelofibrosis

Olatoyosi Odenike
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 545–552.
https://doi.org/10.1182/asheducation-2013.1.545
Published: 2013
Journal Articles

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Stefan N. Constantinescu, William Vainchenker
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 553–560.
https://doi.org/10.1182/asheducation.V2012.1.553.3800163
Published: 2012
Journal Articles

Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms

Nicholas C. P. Cross
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 208–214.
https://doi.org/10.1182/asheducation-2011.1.208
Published: 2011
Journal Articles

Management of Myelofibrosis

Alessandro M. Vannucchi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 222–230.
https://doi.org/10.1182/asheducation-2011.1.222
Published: 2011
Journal Articles

Rethinking Disease Definitions and Therapeutic Strategies in Essential Thrombocythemia and Polycythemia Vera

Claire Harrison
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 129–134.
https://doi.org/10.1182/asheducation-2010.1.129
Published: 2010
Journal Articles

Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2 V617F Era

Ayalew Tefferi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 240–245.
https://doi.org/10.1182/asheducation-2006.1.240
Published: 2006